Wei Keith Tan
Impact in
- Microbiology top 2%
- Antimicrobial Peptides and Activities
- Biotechnology top 10%
- Transgenic Plants and Applications
Papers in
- Surgery 15
- Esophageal Cancer Research and Treatment 12
- Esophageal and GI Pathology 6
- Bladder and Urothelial Cancer Treatments 2
-
- Gastric Cancer Management and Outcomes 4
- Occupational and environmental lung diseases 2
- Sarcoma Diagnosis and Treatment 1
- Ferroptosis and cancer prognosis 1
- Co-authors
- James P. Tam (1 shared paper)Ka H. Wong (1 shared paper)Shujing Wang (1 shared paper)Rebecca C. Fitzgerald (8 shared papers)Saran Shantikumar (1 shared paper)J. E. M. Wigley (1 shared paper)Massimiliano di Pietro (9 shared papers)Hui Meng Tan (4 shared papers)
- Journals
- Endoscopy (2 papers)Clinical Gastroenterology and Hepatology (2 papers)Scientific Reports (2 papers)Pharmaceuticals (1 paper)BMC Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Wei Keith Tan
27 papers receiving 710 citations
Wei Keith Tan's Hit Papers
Peers
Comparison fields: 5 of 73
- Microbiology 231
- Biotechnology 69
- Molecular Biology 322
- Surgery 171
- Gastroenterology 20
Countries citing papers authored by Wei Keith Tan
This map shows the geographic impact of Wei Keith Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Keith Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Keith Tan more than expected).
Fields of papers citing papers by Wei Keith Tan
This network shows the impact of papers produced by Wei Keith Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Keith Tan. The network helps show where Wei Keith Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Keith Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial Peptides from Plants Hit paper breakdown → | 2015 | 380 |
| 2 | 2023 | 67 | |
| 3 | 2018 | 56 | |
| 4 | 2013 | 41 | |
| 5 | 2014 | 31 | |
| 6 | 2008 | 25 | |
| 7 | 2013 | 14 | |
| 8 | 2022 | 13 | |
| 9 | 2016 | 12 | |
| 10 | 1975 | 12 | |
| 11 | 2023 | 10 | |
| 12 | 2025 | 9 | |
| 13 | 2023 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2016 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2023 | 3 |
About Wei Keith Tan
Wei Keith Tan is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Molecular Biology, Rheumatology and Pathology and Forensic Medicine, having authored 28 papers that have together received 719 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (12 papers), Esophageal and GI Pathology (6 papers), Gastric Cancer Management and Outcomes (4 papers), Occupational and environmental lung diseases (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Ferroptosis and cancer prognosis (1 paper) and Urologic and reproductive health conditions (1 paper). The work is most often cited by research in Microbiology (231 citations), Biotechnology (69 citations), Molecular Biology (322 citations), Surgery (171 citations) and Gastroenterology (20 citations). Wei Keith Tan has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include James P. Tam, Ka H. Wong, Shujing Wang, Rebecca C. Fitzgerald, Saran Shantikumar, J. E. M. Wigley, Massimiliano di Pietro, Hui Meng Tan, Christopher C.K. Ho and Wei Phin Tan. Their work appears in journals such as Endoscopy, Clinical Gastroenterology and Hepatology, Scientific Reports, Pharmaceuticals and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.